EPISODE · Jul 23, 2025 · 4 MIN
Harrow Adds Biosimilars to US Portfolio
from Eyewire News: The Podcast · host Eyewire News
Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Harrow Adds Biosimilars to US Portfolio
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m